- Advertisement -

Argentina: Promotion of modern biotechnology and nanotechnology – Lexology

In brief By National Law No. 27,685 ("Law"), published on 16 September 2022, Law No. 26,270 was amended, expanding throughout the entire national territory the...

CRISPR Screening Combined with Chromatin Accessibility Sequencing

New York Genome Center (NYGC) and New York University (NYU) scientists report that they have developed a genetic screening platform that jointly captures CRISPR...

Atlas of malaria parasite gene activity provides new targets for drugs and vaccines

Credit: Real et al. Researchers have mapped in fine detail the genetic changes malaria parasites go through...

Novel method to design new peptide therapeutics pioneered

Hokkaido University researchers have developed a novel method to design and develop peptide antibiotics in large numbers, which will prove critical to controlling antibiotic...

Multiomics in Pancreatic Cancer: A Conversation with Dr. William Hwang

Sponsored content brought to you by Q:  What are some of the biggest challenges in pancreatic cancer? Dr. Hwang: I would start with the unique tumor...

Coral Reef Research Collection wins $100,000 International Science Prize

Credit: (c) ZSL A team of scientific editors has been awarded US $100,000 by Swiss open-access publisher...

NewBiologix and Synastra Join Forces to Advance rAAV Manufacturing for Duchenne...

Switzerland-headquartered NewBiologix signed an agreement with Synastra Biotechnology to develop a stable producer cell line for Synastra’s investigational Duchenne muscular dystrophy (DMD) gene therapy...

Medicines Discovery Catapult Backs Two U.K. Biotech Companies Tackling Chronic Diseases

Medicines Discovery Catapult (MDC) invested in two U.K. biotechs developing new  approaches to treating diseases such as psoriasis. Parkinson’s Flip Therapeutics and Nascent Therapeutics...

NewBiologix and Synastra Join Forces to Advance rAAV Manufacturing for Duchenne Gene Therapy

Switzerland-headquartered NewBiologix signed an agreement with Synastra Biotechnology to develop a stable producer cell line for Synastra’s investigational Duchenne muscular dystrophy (DMD) gene therapy...

Medicines Discovery Catapult Backs Two U.K. Biotech Companies Tackling Chronic Diseases

Medicines Discovery Catapult (MDC) invested in two U.K. biotechs developing new  approaches to treating diseases such as psoriasis. Parkinson’s Flip Therapeutics and Nascent Therapeutics...

Micro-Bladder Model Demonstrates How Phage Therapy Could Help to Reduce Recurrent UTIs

Researchers headed by a team at the Centre for Kidney and Bladder Health, Division of Medicine, University College London, have used a novel human...

more new items

NewBiologix and Synastra Join Forces to Advance rAAV Manufacturing for Duchenne...

Switzerland-headquartered NewBiologix signed an agreement with Synastra Biotechnology to develop a stable producer cell line for Synastra’s investigational Duchenne muscular dystrophy (DMD) gene therapy...

Medicines Discovery Catapult Backs Two U.K. Biotech Companies Tackling Chronic Diseases

Medicines Discovery Catapult (MDC) invested in two U.K. biotechs developing new  approaches to treating diseases such as psoriasis. Parkinson’s Flip Therapeutics and Nascent Therapeutics...

Micro-Bladder Model Demonstrates How Phage Therapy Could Help to Reduce Recurrent...

Researchers headed by a team at the Centre for Kidney and Bladder Health, Division of Medicine, University College London, have used a novel human...